Medtronic (MDT)

Cowper Law LLP Defeats Medtronic's Motion for Summary Judgment in MiniMed Insulin Pump Litigation

Medtronic delivers consistent dividend growth and healthcare innovation, positioning it as a stable investment choice in today's dynamic market environment.

In a welcome move, Medtronic stock saw its Relative Strength Rating improve to 73 on Tuesday, up form 67 a day earlier.

Healthcare sector sees volatility due to UnitedHealth's earnings disappointment, but ETFs like XLV, IHE, and XPH still show resilience and pockets of strength.

The device, known as the Layer 7 Cortical Interface, is a thin, flexible microelectrode array designed to record and stimulate neural activity without penetrating brain tissue.

U.S. major indices traded lower at midday Wednesday, pressured by sharp declines in tech and semiconductor stocks after Washington tightened chip export restrictions to China.

Dexcom stock surged Thursday after the FDA cleared its newest diabetes device for an extended 15-day wear time.

Analyzing MEDTRONIC PLC (NYSE:MDT)'s Dividend Potential.

Uncertainty has cast a pall over medical stocks, which are taking a "wait-and-see" approach to Trump's tariffs.

China is stepping up efforts to reassure U.S. corporate giants like Apple, Pfizer, and Mastercard of its economic potential, with Vice Premier He Lifeng promising a better business environment amid rising U.S. tariff pressures and slowing foreign investment.

Balancing Dividends and Fundamentals: The Case of MEDTRONIC PLC (NYSE:MDT).

MEDTRONIC PLC (NYSE:MDT) Reveals Intriguing Technical Aspects. Indications Suggest NYSE:MDT Could Be on the Verge of a Breakout. Here's What You Need to Know.